SSR 180711 hydrochloride

Pricing Availability   Qty
说明: Selective α7 nAChR partial agonist
化学名: 4-Bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate hydrochloride
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for SSR 180711 hydrochloride

SSR 180711 hydrochloride is a partial agonist at α7 nAChR. Enhances episodic memory and reverses MK-801-induced deficits in retention of episodic memory. Increases extracellular dopamine levels in rat prefrontal cortex. Also exhibits antidepressant-like properties.

技术数据 for SSR 180711 hydrochloride

分子量 361.66
公式 C14H17BrN2O2.HCl
储存 Store at -20°C
纯度 ≥98% (HPLC)
CAS Number 446031-79-4
PubChem ID 9928899
InChI Key YNBXNVUZXFMNSJ-UHFFFAOYSA-N
Smiles O=C(N1C2CCN(CC2)CC1)OC3=CC=C(Br)C=C3.Cl

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for SSR 180711 hydrochloride

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
water 36.17 100
DMSO 36.17 100

制备储备液 for SSR 180711 hydrochloride

以下数据基于产品分子量 361.66。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 2.77 mL 13.83 mL 27.65 mL
5 mM 0.55 mL 2.77 mL 5.53 mL
10 mM 0.28 mL 1.38 mL 2.77 mL
50 mM 0.06 mL 0.28 mL 0.55 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for SSR 180711 hydrochloride

参考文献 for SSR 180711 hydrochloride

参考文献是支持产品生物活性的出版物。

Jones et al (2014) Effect of α7 nicotinic acetylcholine receptor agonists on attentional set-shifting impairment in rats. Psychopharmacology (Berl). 231 673 PMID: 24057763

Pichat et al (2007) SSR180711, a novel selective α7 nicotinic receptor partial agonist: (II) efficacy in experimental models predictive of activity against cognitive symptoms of schizophrenia. Neuropsychopharmacology 32 17 PMID: 16936709


If you know of a relevant reference for SSR 180711 hydrochloride, please let us know.

按产品操作查看相关产品

查看全部 Nicotinic (α7) Receptor Agonists

关键词: SSR 180711 hydrochloride, SSR 180711 hydrochloride supplier, SSR180711, hydrochloride, partial, agonists, a7, nAChR, nicotine, acetylcholine, receptor, schizophrenia, episodic, memory, antidepressant, Nicotinic, (a7), Receptors, 5559, Tocris Bioscience

篇 SSR 180711 hydrochloride 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 SSR 180711 hydrochloride 的引用文献。 您是否知道使用了 Tocris SSR 180711 hydrochloride 的优秀论文? 请告知我们.

SSR 180711 hydrochloride 的评论

目前没有该产品的评论。 Be the first to review SSR 180711 hydrochloride and earn rewards!

Have you used SSR 180711 hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Nicotinic ACh Receptors Scientific Review

Nicotinic ACh Receptors Scientific Review

Updated in 2014, this review by Sue Wonnacott summarizes the diverse structure and function of nicotinic acetylcholine receptors and gives an in-depth review of the ligands available for nAChR research. Compounds available from Tocris are listed.

Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.